Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Gb Sciences' cannabinoid-containing formulations to be tested in rodent models of Parkinson's

April 13, 2022

Seed financing supports PolyCore's development of PCT-3012 for Parkinson's disease

April 12, 2022

MJFF grant supports use of Lucy Therapeutics' mitochondrial platform to target Parkinson's disease

April 12, 2022

Changes in the adaptive immunity of PD mice models carrying LRRK2 mutations drive neurodegeneration

April 12, 2022

TLR9 inhibitor-loaded nanoparticles protect against radiation-induced BBB disruption

April 12, 2022

Targeting 5-HT1AR as novel therapeutic strategy for Fragile X syndrome

April 12, 2022

Janssen describes new Casein kinase I isoform delta inhibitors

April 12, 2022

GPR171 agonism ameliorates chronic neuropathic and inflammatory pain

April 8, 2022

1st Bio Therapeutics presents new protein kinase inhibitors

April 8, 2022

Alternate approach could enable earlier detection, intervention, in Alzheimer's

April 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...